Byung-Tae Noh

Amministratore Delegato presso DAE HWA PHARMACEUTICAL CO., LTD.

Patrimonio netto: 460 898 $ in data 30/04/2024

62 anni

Health Technology

Consumer Services

Profilo

Byung-Tae Noh is currently the Chairman & Co-Chief Executive Officer at DAE HWA PHARM Co., Ltd.
He previously worked as a Director at RedoxBio Co., Ltd.
Mr. Noh completed his undergraduate degree at Daegu University.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. 0.41%	31/03/2023	100 000 ( 0.41% )	239 971 $	31/12/2020
DAE HWA PHARM CO., LTD. 0.15%	27/12/2023	27 583 ( 0.15% )	220 927 $	30/04/2024

Posizioni attive di Byung-Tae Noh

Società	Posizione	Inizio
DAE HWA PHARMACEUTICAL CO., LTD.	Amministratore Delegato	20/03/2015

Tutte le posizioni attive di Byung-Tae Noh

Precedenti posizioni note di Byung-Tae Noh

Società	Posizione	Fine
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea.	Direttore/Membro del Consiglio	-